The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Alvotech ( ($ALVO) ) has issued an update. On November 2, 2025, Alvotech announced that the U.S. FDA issued a complete response letter for its ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

Alvotech (ALVO) said Monday that the U.S. Food and Drug Administration issued a complete response letter for its biologics ...

The Third Economic Forum on Genetic Resources, titled ‘GenoBusiness Forum’, highlighted the fundamentals of natural resources in Dhofar and called for necessary innovation to tap the resources. The ...

Following submissions from both sides, Mohali chief judicial magistrate Megha Dhaliwal dismissed the VB’s application for ...

The modern era of biobased innovation was catalyzed by policy action. In 1999, President Bill Clinton issued Executive Order ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Medical technology, the pharmaceutical industry and biotechnology are sectors in which sensors and measurement technology are increasingly being used to improve quality and efficiency. Micro-Epsilon ...